Search Results - "Zvi, H. Ben"

Comparison of clinical outcomes of influenza A and B at the 2017–2018 influenza season: a cohort study by Avni, T., Babich, T., Nir, A., Yahav, D., Shaked, H., Sorek, N., Zvi, H. Ben, Bishara, J., Atamna, A.

“…Influenza has significant morbidity and mortality. Some experts consider infection with influenza B as milder than that with influenza A. The objective of this…”
Get full text

Multidrug-resistant Acinetobacter baumannii infections in lung transplant patients in the cardiothoracic intensive care unit by Biderman, P., Bugaevsky, Y., Ben-Zvi, H., Bishara, J., Goldberg, E.

“…Background Multidrug‐resistant (MDR) gram‐negative bacteria are a growing threat to solid organ transplantation (SOT) patients in the intensive care unit…”
Get full text

Monomicrobial necrotizing fasciitis in a single center: the emergence of Gram-negative bacteria as a common pathogen by Yahav, D, Duskin-Bitan, H, Eliakim-Raz, N, Ben-Zvi, H, Shaked, H, Goldberg, E, Bishara, J

“…Highlights • Gram-negative necrotizing fasciitis is common • Mostly in immunocompromised or post-operative patients • The most common pathogen is E. coli •…”
Get full text

Colistin exposure as a risk factor for infections caused by inherently colistin resistant Enterobacteriaceae—a case–control study by Drozdinsky, G., Ben-Zvi, H., Kushnir, S., Leibovici, L., Yahav, D.

“…Epidemiological studies have suggested an association between increased colistin use and selection for inherently colistin-resistant Enterobacteriaceae (ICRE)…”
Get full text

The effect of statins on the outcome of Clostridium difficile infection in hospitalized patients by Atamna, A., Yahav, D., Eliakim-Raz, N., Goldberg, E., Ben-Zvi, H., Barsheshet, A., Elis, A., Bishara, J.

“…Several studies have shown an association between exposure to statins and favorable clinical outcomes for various types of infections. We aimed to assess the…”
Get full text

Characterization of hepatitis delta infection in Israel: prevalence and genotypes by Shirazi, R, Ram, D, Rakovsky, A, Gozlan, Y, Bucris, E, Shaked-Mishan, P, Picard, O, Shemer-Avni, Y, Ben-Zvi, H, Halutz, O, Mor, O, Lurie, Y, Safadi, R, Ben-Ari, Z

Get full text

95 Achromobacter xylosoxidans in cystic fibrosis patients: prevalence and clinical significance by Bar-On, O, Mussaffi, H, Ben-Zvi, H, Mei-Zahav, M, Prais, D, Steuer, G, Stafler, P, Levine, H, Blau, H

Get full text

P222 Airway Achromobacter xylosoxidans and disease severity in cystic fibrosis by Bar-On, O., Stafler, P., Mei-Zahav, M., Ben-Zvi, H., Blau, H., Mussaffi, H., Prais, D.

Get full text

PP194 [Infections » Infections in the critical care unit]: MAJOR CLINICAL PREDISPOSING EVENTS IN HIGH-RISK, POSTOPERATIVE, PEDIATRIC CARDIAC PATIENTS – A NOVEL ASSOCIATION WITH BACTEREMIA by Shostak, E., Schiller, O., Amir, G., Georgy, F., Shochat, T., Livni, G., Ben Zvi, H., Manor, O., Dagan, O.

Get full text

113 In vitro antimicrobial activity of the novel antimicrobial peptide OMN-51 against multidrug-resistant Pseudomonas aeruginosa isolated from people with cystic fibrosis by Heching, M., Zvi, H. Ben, Glick, R., Slomiansky, L., Weinberg, J., Oholy, M., Moses, R., Nur, N., Maurice, E. Chass, Mandel, S., Bachnoff, N., Kramer, M.

Get full text

(699) No Association Between BNT162B2 Vaccine and Graft Rejection Among Lung Transplant Recipients by Shostak, Y., Kramer, M., Bakal, I., Edni, O., Gluzman, A., Shafran, N., Rosengarten, D., Shitenberg, D., Heching, M., Amor, S., Zvi, H. Ben, Pertzov, B., Israeli, M., Peysakhovich, Y., Barac, Y., Shtraichman, O.

“…Safety of the BNT162b2 vaccine has been described among the general population and solid organ transplant recipients (SOTR). Post vaccination development of…”
Get full text

P640 Serologic response and safety after third dose of the COVID-19 BNT162b2 vaccine in patients with Inflammatory Bowel Diseases by Edelman-Klapper, H, Rabinowitz, K M, Zittan, E, Bar-Gil Shitrit, A, Goren, I, Avni-Biron, I, Ollech, J E, Lichtenstein, L, Banai-Eran, H, Yanai, H, Snir, Y, Pauker, M H, Friedenberg, A, Levy-Barda, A, Segal, A, Broitman, Y, Maoz, E, Ovadia, B, Aharoni Golan, M, Shachar, E, Ben-Horin, S, Mor, M, Ben Zvi, H, Perets, T T, Eliakim, R, Barkan, R, Navon, M, Gal-Tanamy, M, Freund, N T, Goren, S, Cohen, D, Dotan, I

“…Abstract Background Vaccines are pivotal for control of the ongoing coronavirus disease (COVID-19) pandemic. Patients with inflammatory bowel diseases (IBD)…”
Get full text

SAT-154 - Characterization of hepatitis delta infection in Israel: prevalence and genotypes by Shirazi, R., Ram, D., Rakovsky, A., Gozlan, Y., Bucris, E., Shaked-Mishan, P., Picard, O., Shemer-Avni, Y., Ben-Zvi, H., Halutz, O., Mor, O., Lurie, Y., Safadi, R., Ben-Ari, Z.

Get full text

P313 Within, 6 months from COVID-19 BNT162b2 vaccine patients with Inflammatory Bowel Diseases treated with Anti-TNFα have significantly lower serologic responses by Rabinowitz, K M, Navon, M, Edelman-Klapper, H, Zittan, E, Bar-Gil Shitrit, A, Goren, I, Avni-Biron, I, Ollech, J E, Lichtenstein, L, Banai-Eran, H, Yanai, H, Snir, Y, Pauker, M H, Friedenberg, A, Levy-Barda, A, Segal, A, Broitman, Y, Maoz, E, Ovadia, B, Aharoni Golan, M, Shachar, E, Ben-Horin, S, Perets, T T, Ben Zvi, H, Eliakim, R, Barkan, R, Goren, S, Krugliak, N, Werbner, M, Alter, J, Dessau, M, Gal-Tanamy, M, Cohen, D, Freund, N T, Dotan, I

“…Abstract Background While vaccines against COVID-19 are effective in healthy individuals, we reported significantly lower serologic responses to BNT162b2 in…”
Get full text

Chills during hemodialysis: prediction and prevalence of bacterial infections – a retrospective cohort study by Shepshelovich, D., MD, Yelin, D., MD, Or Bach, L, Halevy, N, Ziv, Y, Green, H., MD, Rozen-Zvi, B., MD, Ben-Zvi, H., MD, Bishara, J., MD, Gafter-Gvili, A., MD, Yahav, D., MD

“…Abstract Introduction Chills are a complication of patients undergoing hemodialysis. The rate of infection among hemodialysis patients presenting with chills…”
Get full text